EUIPO The displayed mark can be extended.
Click here, to extend trademark protection for a further 10 years.
Protect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark NUCLEIX was filed as Word mark on 05/11/2015 at the European Union Intellectual Property Office.
It was registered as a trademark on 04/07/2016.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 014048607 |
| Application date | May 11, 2015 |
| Publication date | December 30, 2015 |
| Entry date | April 7, 2016 |
| Expiration date | May 11, 2025 |
Trademark owner
27 HaBarzel St.
69710 Tel-Aviv
IL
69710 Tel-Aviv
IL
Trademark representatives
Harcourt Centre, Block 4 Harcourt Road
D02 HW77 Dublin
IE
goods and services
1
Reagents for scientific or research use; chemical preparations to be used in biochemical and clinical research; diagnostic preparations for laboratory use, namely, for forensic laboratory use
5
Diagnostic test kits for medical and clinical use comprising reagents for use in identifying and measuring changes associated with cancer or precancerous conditions; assay kit comprising reagents for use in identifying and measuring changes associated with cancer or precancerous conditions; medical diagnostic kits for use in the field of cancer detection; reagents and/or buffers, sold separately or in laboratory kit form, using epigenetic markers for diagnosis of cancers; diagnostic preparations for laboratory use, namely, for clinical or medical laboratory use
9
Computer software for use in the field of medical, clinical, diagnostic or laboratory analysis; computer software for controlling the operation of medical test equipment and test results; software for analyzing the results of biochemical assays for detection of cancer
10
Clinical and medical laboratory (in vitro) medical testing apparatus for diagnosing cancer, in particular ones containing biochemical reagents
42
Pharmaceutical drug research and development, consulting services in the fields of biotechnology; custom assay development
44
Consulting services in the field of health; consulting services in the field of diagnostic medical testing; medical analysis for the diagnosis of the cancer and prognosis of expected progression of the disease; medical testing for diagnostic or treatment purposes in the fields of the detection and treatment of cancer; providing cancer screening services; providing a website featuring information on the signs and symptoms of cancer, causes of cancer, risk factors for cancer
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| October 13, 2024 | Extension, Notification of expiry of trade mark | ||
| January 13, 2023 | Change Representative, Published | ||
| January 11, 2021 | Change Representative, Published | ||
| January 7, 2021 | RAW: Representative - Deletion of the representative, Published |
ID: 11014048607